Studies that provide an overview of ethical dilemmas use a range of methodologies, including the use of hypothetical scenarios, 29, 31, 33 case scenarios, 30, 34 focus groups, 32 and surveys. [26] [27] [28] However, none of these studies have documented the comprehensive range of ethical dilemmas currently encountered in practice. They do not provide specific data concerning the frequency of ethical dilemmas encountered or the range of management strategies used when ethical dilemmas of genetic testing arise. Therefore, there is limited information about the current incidence of ethical dilemmas in clinical genetics practice, leaving uncertainty about whether theoretical assumptions about potential ethical dilemmas are borne out in clinical practice.
This study aimed to document the range and frequency of ethical dilemmas occurring in clinical genetic testing in Australasia. The study also aimed to document the management strategies used when such ethical dilemmas of genetic testing arise.
Purpose: The aim of this study was to document the range and frequency of ethical dilemmas associated with genetic testing encountered by genetic health professionals and to determine the strategies used to manage them.
Methods: An online survey was used to document how often the 11 key ethical dilemmas have been encountered; whether any additional dilemmas have been encountered; and how these dilemmas have been managed. Members of the Australasian Association of Clinical Geneticists, Australasian Society of Genetic Counsellors, and genetic social workers practicing in Australia and New Zealand were invited to participate.
results:
A total of 102 responses were received (31% response rate). Respondents had encountered all of the 11 ethical dilemmas included in the survey, and 18 respondents had encountered 14 additional dilemmas. Respondents encountered an average of 2.2 dilemmas per year of practice. Peer and clinical supervision were the most common strategies used to manage dilemmas, and seeking advice from clinical ethics committees was rare. Occasionally, respondents facilitated practices they deemed unethical as a consequence of client deception.
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MatErIals and MEthods survey development
The survey contained two sections: demographics and ethical dilemmas (see Supplementary Data online). To develop the section concerning ethical dilemmas, the research team identified a range of key ethical dilemmas from past literature and discussions with colleagues. These were then reviewed and narrowed down to 11 mutually exclusive ethical dilemmas through dialogue within the research team and with clinical colleagues. A summary of these 11 ethical dilemmas is presented in Table 1 .
Respondents were asked a series of questions about each of the 11 ethical dilemmas, which included whether they had encountered the dilemma, how many times they had encountered it, and the range of strategies they had used to manage it. Management strategies identified in previous studies were used as a guide for drafting the range of management strategies to include in the survey for each ethical dilemma, 27 ,28 although respondents were also able to specify additional management strategies if the list provided in the survey was not exhaustive. If the ethical dilemma related to the provision of a genetic test (as opposed to, for example, a dilemma about whether to disclose information obtained as a consequence of a genetic test), respondents were also asked how often they had refused to provide such a test. At the end of each ethical dilemma, an openended question asked for further comments. This section also allowed respondents to provide information about additional ethical dilemmas they had encountered in relation to genetic testing.
The survey was piloted on three genetic counselors and one clinical geneticist. Their comments and recommendations were used to amend the survey before it was sent out to the wider cohort of potential respondents. The situation in which the assumed father is not the biological father.
Whether to disclose the information and if so to whom.
Incest
21
A sexual relationship between two close relatives, e.g., father and daughter or siblings.
Whether to disclose the information and if so to whom; whether to report to the legal authorities.
3, 4
Predictive testing of immature/mature minors for adult-onset conditions 12, 17 Testing of someone who has not reached the age of majority for a condition that generally has onset in adulthood and for which no effective prevention is available.
Whether it is acceptable to override the child's future autonomy (for immature minors); whether testing will cause harm to the child (for immature and mature minors).
5
Predictive testing of competent third parties 25 Genetic testing of someone who has full mental capacity without his/her knowledge or consent, at the request of a relative or other third party.
Whether it is acceptable to test competent individuals without informed consent; whether the needs of a third party can ever outweigh those of the person being tested.
6
Predictive testing of a monozygotic twin 19 Genetic testing in which one twin wishes to know his/her genetic status but the other does not.
Whether the right of one twin to know his/her genetic status outweighs the right of the other twin to not know. Making use of PGD or prenatal testing to determine the sex of an embryo/fetus to fulfill parental wishes for a child of a specific gender.
Whether it is appropriate to use genetic technologies to balance families or facilitate cultural or personal beliefs about gender preference.
9
Selection for a disability 3, 10 Selection of embryos or a fetus using genetic technologies to ensure the birth of a child with a disability.
How to determine appropriate limits to procreative autonomy; whether the use of genetic technology should be limited to avoiding disability.
10
PGD to immunologically match a sibling to a sick child [4] [5] 11 Selecting an embryo with a human leukocyte antigen-type match to save the life of a sick older sibling.
Whether parents have the right to produce a child for the purpose of saving another child; the potential for harm to the children.
11
Nondisclosure of genetic status to at-risk relatives 14, 16, 18 A situation in which a family member knows his/her genetic status for a condition, but will not share this information with other family members who are at risk of the condition, despite knowing they may benefit from this information.
Whether the client has a right to confidentiality in circumstances in which there is considerable potential for harm to known relatives if information is not shared.
PGD, preimplantation genetic diagnosis. The frequency of each ethical dilemma was calculated by dividing the total number of cases encountered by all respondents by the total number of years all respondents had been practicing.
Open-ended questions regarding additional ethical dilemmas encountered and additional management strategies used were categorized using content analysis by multiple members of the research team to ensure consistency. 35 This involved placing each response into a category to describe the type of ethical dilemma it represented, and then comparing and contrasting these categories until a final list of mutually exclusive and discrete categories was achieved. All four authors were involved in this process until consensus was reached.
Ethics committee approval
Ethics committee approval was obtained from the Royal Children's Hospital, Melbourne, (HREC-31070A) and the University of Melbourne (1135986).
rEsults respondents
Responses were received from 31 members of the Australasian Association of Clinical Geneticists, 84 members of the Australasian Society of Genetic Counsellors, and 5 genetic social workers. Of these respondents, two listed their profession as "researcher, " one as "oncologist, " and one as "family history assessor, " and were therefore excluded from the analysis. Responses from one clinical geneticist and eight genetic counselors were also excluded from analysis because these individuals did not see clients for genetic consultation on a regular basis. Responses from one clinical geneticist, three genetic counselors, and one genetic social worker were excluded because they did not provide any responses to the questions concerning ethical dilemmas.
The remaining 102 responses (31.3% response rate) from 26 clinical geneticists (37.6% response rate), 72 genetic counselors (29.1%), and 4 genetic social workers (40.0%) were analyzed in detail. The Australasian Society of Genetic Counsellors was unable to provide the exact number of professionals on their list who were practicing genetic counselors, and so it is likely that the response rate is an underestimation through inclusion of those not currently practicing and thus not eligible to respond.
demographics
The demographic information provided by respondents is summarized in Table 2 . Most respondents were female (84.0%), aged 49 years or younger (78.8%), and Caucasian (94.7%). The mean number of years that respondents had been practicing was 9.9 years (SD = 7.9), and the mean number of clients they saw per week was 6.6 (SD = 3.3). A majority of respondents spent ≥50% of their time on client-related activities (78.7%).
Ethical dilemmas encountered
Each of the 11 ethical dilemmas included in the survey had been encountered by at least some of the respondents. Table 3 summarizes the number of respondents who had encountered each of these ethical dilemmas.
Three of the ethical dilemmas were encountered by over half of the respondents: testing at 25% risk (encountered by 71 respondents (71.0%)); requests for predictive genetic testing of mature minors (encountered by 68 respondents (67.3%)), and nondisclosure of genetic status to at-risk relatives (encountered by 63 respondents (63.0%)).
The only two ethical dilemmas demonstrating statistically significant differences between participant groups were requests for predictive genetic testing of mature and immature minors. In these cases, a much higher percentage of clinical geneticists had encountered these ethical dilemmas in comparison with genetic counselors.
The ethical dilemma encountered by respondents most frequently was nondisclosure of genetic status to at-risk relatives (0.5 cases per year of practice (SD = 1.0)). Overall, respondents encountered an average of 2.2 ethical dilemmas per year of practice (SD = 2.3).
A total of 18 respondents reported 14 additional ethical dilemmas (Table 4) they had encountered regarding genetic testing that were not included in the survey. The most common of these dilemmas, each reported by three respondents, were clients who declined to receive results from predictive testing and requests for genetic testing of individuals who had reduced cognitive capacity or who lacked social support.
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Management strategies used and outcomes of ethical dilemmas
Outcomes for each of the ethical dilemmas along with the three most used management strategies are presented in Table 5 . It was common for respondents to have clients withdraw requests for an ethically contentious genetic test following genetic counseling. Respondents commonly consulted their peers and clinical supervisors. Respondents also used professional guidelines and the ability to refer clients to other health professionals in some instances. A range of additional management strategies were also provided to respondents within the survey, but respondents indicated use of these strategies less frequently. For example, one potential management strategy included in the survey was consultation with a clinical ethics committee, yet for 5 of the 11 ethical dilemmas, not a single respondent indicated they had used this management strategy. For the other six ethical dilemmas, the percentage of respondents who had sought advice from a clinical ethics committee ranged from 2.6% (in relation to the dilemma of misattributed paternity) to 14.3% (in relation to the dilemma of selecting for a disability).
Inadvertent provision of tests deemed unethical
Some respondents had inadvertently provided genetic tests they deemed to be unethical as a consequence of client deception or withholding of information. In these instances, respondents only became aware of their clients' true motivation for testing after the test had been provided. Three respondents reported clients requesting prenatal chromosome testing to exclude a major genetic abnormality, only to find that upon provision of results, the clients' true motivation for testing was to determine the fetal gender for the purpose of sex selection. Another respondent reported providing testing to a couple who both had achondroplasia, an autosomal dominant condition. It is common practice to provide prenatal testing in this circumstance because homozygosity for the FGFR3 mutation that underlies this condition is incompatible with life, and therefore many couples choose to terminate a pregnancy when this is found. However, the test can also reveal a heterozygous fetus with achondroplasia. When testing identified a child with no FGFR3 mutation and therefore of average stature, the couple revealed their true intent, which was to terminate the pregnancy. However, in this case, after counseling, the couple elected to continue the pregnancy.
dIscussIon
This study documented the range and frequency of ethical dilemmas regarding genetic testing encountered by Australasian genetic health professionals. The study also gathered information about the management strategies used in response to these dilemmas. The study offers an important empirical contribution to the largely theoretical discussions that currently exist regarding ethical dilemmas in clinical genetics practice. The major findings of this study were as follows: (i) a significant range of ethical dilemmas are occurring regularly in clinical genetics practice, many of which are likely to challenge genetic health professionals; (ii) a range of management strategies are used by genetic health professionals when they encounter such ethical dilemmas, with peer and clinical supervisor consultation being most commonly used and seeking advice from a clinical ethics committee rarely used; (iii) occasionally, genetic health professionals inadvertently provide tests they deem to be unethical as a consequence of client deception or withholding of information. Given that the provision of genetic testing is rapidly expanding to other areas of medicine, it is important for health professionals to increase their awareness of the range Reproductive assistance for clinically affected individuals with uncertain ability to care for a child Requests for prenatal diagnosis for "mild" conditions Requests for termination of pregnancy for "mild" birth defects Sex selection against carriers of genetic conditions a Here the grandparent from whom the gene of interest has been inherited is ascertained via linkage analysis rather than a direct test for the genetic mutation. This allows the parents to choose to terminate a pregnancy at 50% risk without learning whether the at-risk parent has the mutation or not.
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of ethical dilemmas currently occurring in relation to genetic tests and also to increase their working knowledge of potential strategies for managing these when they arise.
Each of the 11 ethical dilemmas included in the survey were encountered by at least a portion of respondents, and 14 additional ethical dilemmas were also documented. On average, genetic health professionals encountered 2.2 ethical dilemmas per year of professional practice. This indicates that genetic health professionals are encountering ethical dilemmas on a regular basis. The finding that each of the 11 ethical dilemmas included in the survey had been encountered by health professionals also indicates that existing literature concerning ethical dilemmas of clinical genetics has identified many ethical dilemmas that are relevant to current practice. The finding of 14 additional ethical dilemmas that were not included in the survey highlights that the 11 ethical dilemmas included in the survey do not constitute an exhaustive list of ethical dilemmas encountered by genetic health professionals. The variety of ethical dilemmas being encountered in current practice highlights the challenges associated with the provision of genetic tests and also the difficulties in preempting all dilemmas prospectively.
Although there were significant demographic differences between clinical geneticists and genetic counselors, significant differences were not found between these groups with regard to the number of ethical dilemmas encountered (with the exception of genetic testing of immature and mature minors).
Respondents reported that they used a range of strategies to manage the ethical dilemmas they encountered in relation to genetic testing. Two key strategies were used across the majority of ethical dilemmas. These were consulting peers (including other genetic health professionals and/or professionals from other fields, e.g., medical ethicists) and consulting clinical supervisors. Our results suggest that genetic health professionals value and rely on the experience and expertise of others when managing ethical dilemmas associated with genetic testing.
Access to clinical supervision in Australasia has become an integral aspect of practice, which is reflected in the Australasian Society of Genetic Counsellors Code of Ethics. 36 Similarly, in the United Kingdom, supervision is highly recommended for genetic health professionals. 37 By contrast, in the United States, clinical supervision is largely seen as a means of training genetic The figures for these outcomes do not add to 100% because some respondents had more than one outcome for the same situations on different occasions.
counselors rather than being used once working in this profession. 38 Supervision is important for genetic health professionals in allowing space and time to think about psychosocial aspects of cases, for sharing perspectives, and exploring new ideas with a trusted supervisor or group of colleagues. 38 As genetic testing moves from the genetic health profession to other areas of medicine more broadly, it may be important to consider the role of clinical supervision also, particularly in specialties in which this is not a traditional or common aspect of clinical practice.
Respondents rarely referred clients to another professional, whether it was a colleague in the genetic health profession or a colleague in a different health profession. However, the exception was the request for preimplantation genetic diagnosis to immunologically match a sibling to a sick child. Here, genetic health professionals are unable to provide the test themselves and so tend to refer to another professional who is able to do so. The lack of referral to other professionals, combined with the high rate of consultation with peers and/or a supervisor, could suggest that genetic health professionals believe they are well equipped with the necessary skills to manage these ethical dilemmas, but wish to seek reassurance and advice from other health professionals. Another possible explanation for not referring clients to other professionals is that genetic health professionals believe that doing so would disrupt the clinical and therapeutic relationship, and thus cause greater distress for the client.
Referring cases to a clinical ethics committee for review and discussion was seldom used as a management strategy by respondents. For many of the ethical dilemmas included in the survey, this strategy was not used by any respondent. Clinical ethics committees are a developing part of the Australian health system, offering timely and focused advice to clinicians facing ethical issues that arise in medicine. 8 However, genetic health professionals may not be aware that this resource is available to them or may not feel that these committees have more expertise than their peers or supervisors who may be ethicists themselves or have training in ethics in cases related to genetic testing. A similar lack of referral to clinical ethics committees has been reported to occur in the United Kingdom. 39 Few respondents, except in cases in which genetic testing of minors was the ethical dilemma, indicated they had consulted professional guidelines. This may be due to genetic health professionals relying on their personal moral beliefs or relying on professional codes of ethics more broadly. It might also be the case that genetic health professionals' working knowledge of existing guidelines is strong enough to eliminate the need to refer to them again. It should also be noted that guidelines do not exist for all of the ethical dilemmas included in the survey, although they do exist for some specific ethical issues, including sex selection for nonmedical reasons. More general codes of ethics have also been developed by professional genetics associations and disease-specific associations, for example, the International Huntington Association. Very little research related to the use of these guidelines by genetic health professionals has been undertaken to date.
Although genetic health professionals often refuse testing when controversial ethical dilemmas arise, in some cases, genetic health professionals reported that they had inadvertently provided genetic tests they deemed to be unethical as a consequence of client deception or withholding of information. For example, in three cases, respondents reported that clients had requested prenatal testing to exclude genetic abnormalities, only to find that the true motivation of the clients for testing had been to determine the gender for sex selection. This is an unavoidable consequence of genetic technology, yet one that is likely to leave genetic health professionals feeling uncomfortable. In these circumstances, it is important that health professionals are able to access formal de-briefing and support.
In some cases, genetic health professionals also provided tests that are viewed as highly controversial in current literature. One respondent received two requests to perform a genetic test to select a child with a BRCA mutation, and the respondent reported providing the test in both cases. Mutations in BRCA1 and BRCA2 convey an increased but not absolute risk of developing cancer. Unlike the situation with conditions such as achondroplasia or deafness, for which a child without the mutation may have difficulty fitting into the specific community of affected individuals, 22 there is no equivalent community for BRCA1/2 mutation carriers. In addition, unlike the mutations associated with deafness, BRCA mutations can be life threatening. There is currently no literature concerning selection for BRCA mutations, and the respondent who encountered this dilemma provided no additional information to clarify the reasons for these requests.
comparisons with other studies
This is the first study to quantitatively document the frequency of ethical dilemmas related to genetic testing in a comprehensive way. Studies of United States, Australian, and Spainish genetic counselors have gathered information about the frequency of a variety of ethical dilemmas in clinical genetics practice, but these studies used a dichotomous variable-"frequent" or "not frequent"-which means that precise documentation of the frequencies was not possible. Also, no definition of these terms was given to respondents in these studies, and therefore respondents' interpretation of the terms "frequent" and "not frequent" might have varied. [26] [27] [28] Clarke and colleagues 14 used a prospective study design to document 65 instances of nondisclosure of genetic status to at-risk relatives over a 12-month period in the United Kingdom and in two Australian centers. However, nondisclosure was the only ethical dilemma related to genetic testing that was included in that study.
The series of surveys of genetic counselors from the United States, Australia, and Spain also asked respondents for strategies they would advise colleagues to use in relation to the professional and ethical issues the survey covered. [26] [27] [28] The original survey revealed a variety of strategies for managing ethical concerns, including: referring to another professional, referring to professional guidelines, disregarding personal beliefs or biases, and determining boundaries within the family. 28 Australian genetic counselors were found to use 8 of the 11 strategies referred to, 27 and Spanish genetic counselors were found to use 10 of the strategies and one additional strategy-"study of the family group. " 26 The finding of this study, that genetic health professionals commonly seek advice from their peers, contrasts with the survey of genetic counselors in Australia, which found that only a small proportion of genetic counselors (15.4%) would recommend discussion with other health professionals. 27 Although these previous surveys have provided some information about strategies for managing ethical dilemmas, they posed only hypothetical questions, asking respondents what they would advise a colleague to do when encountering an ethical dilemma but not what they do, or have done, in their own practice. This is a key difference between our study and these past studies.
Two additional studies have examined the management strategies used by geneticists in relation to nondisclosure of genetic status to at-risk family members specifically. 14, 18 These found that clinical geneticists used a range of management strategies in encouraging the disclosure of genetic risk information, including: consulting colleagues, case conferences, ethics committees, published guidelines, and family letters.
study limitations and future research
The results from this study provide validation for the extensive body of literature concerning ethical dilemmas associated with genetic testing, yet they are limited to the experiences of genetic health professionals working only in Australasia. The response rate for the survey (31.3%) means there may be other dilemmas and management strategies that were not identified in this study and the results cannot be generalized to all genetic health professionals. The survey instrument was not validated and given that the study was retrospective, it is likely that respondent recall of the ethical dilemmas, including the frequency and the management strategies used, was not precise. It is also possible that because the lines between ethical, professional, practical, and moral dilemmas are often blurred, respondents might have omitted to report some past cases as a consequence of not perceiving them to be ethical in nature. Complementing this study with further research using a qualitative approach would be valuable in providing a better perspective regarding these biases. A prospective study would be valuable in providing accurate data on the ethical dilemmas as they occur, their frequency, and the range of management strategies used over a set period of time.
conclusion
Demand for genetic testing is increasing, and the provision of these tests no longer falls solely to genetic health professionals, but to a range of health professionals more broadly. It is therefore important to increase awareness among the medical community about the ethical dilemmas that regularly occur in relation to genetic testing, and the ways in which these can be managed. Findings from our study indicate that health professionals who regularly provide genetic tests are likely to encounter a range of ethical dilemmas. The study also highlights the often challenging nature of such dilemmas and that, occasionally, the provision of tests deemed to be unethical is unavoidable. Health professionals providing genetic tests will require knowledge about these common ethical aspects of practice and they might also require ongoing training, support, and assistance to help navigate such dilemmas competently. Findings from this study provide an important step toward ensuring that guidance, training, education, and support are evidence based and align with current clinical practice.
SuPPLEMENtaRy MatERIaL
Supplementary material is linked to the online version of the paper at http://www.nature.com/gim 
